AMA submission to the TGA advisory committee on medicines scheduling – proposals to downschedule mometasone and to advertise glyceryl trinitrate

The AMA opposes the proposal to downschedule certain dermal-use preparations of mometasone from a medicine only available by prescription to an over-the-counter medicine. The AMA also does not support the proposal to allow glyceryl trinitrate to be advertised directly to the public.